9MH MedX Health Corp.

MedX Health Corp. Adds Experienced Medical Device Professional, Scott Spearn, as President, to Build Sales and Expand Sales Channels

MISSISSAUGA, Ontario--(BUSINESS WIRE)--

MedX Health Corp. (“MedX”) (TSX-V: MDX) announced today that Scott Spearn, an experienced medical device executive, joined the MedX team as President. Mr. Spearn has successfully built sales and distribution channels for medical devices across Canada, the United States and Latin America. His focus will be on developing and expanding MedX’s North American and international sales. Mr. Spearn will report to Robert von der Porten, CEO.

“With the completion of successful financings and the fact that we are well along the path to launching our telemedicine platform, MedX is well positioned to grow existing markets and enter new ones. Scott’s proven abilities and experience will play a significant role in getting MedX to the next level. We are very pleased that he is joining our team,” said Mr. von der Porten.

“I am very excited to be joining the Company because MedX’s SIAscope and laser technologies are exceptional and are helping change people’s lives for the better. I am excited about being part of the MedX team and to help grow its business on a global basis,” Mr. Spearn said.

About MedX

MedX, headquartered in Mississauga, Ontario, is a leading medical device company focused on skin cancer with its SIAscopy technology that is imbedded in its products SIAMETRICS™, SIMSYS™, and MoleMate™, which MedX manufactures in its ISO 13485 certified facility. SIAMETRICS™, SIMSYS™, and MoleMate™ include hand-held devices that use patented technology utilizing light and its remittance to view up to 2 mm beneath suspicious moles and lesions in a pain free, non-invasive manner, with its software then creating real-time images for physicians and dermatologists to evaluate all types of moles or lesions within seconds. These products are Health Canada, FDA (US), ARTG and CE cleared for use in Canada, the US, Australia, New Zealand, the European Union and Turkey. MedX also designs, manufactures and distributes quality laser and light therapy technologies to provide drug free and non-invasive treatment of tissue damage and pain. www.medxhealth.com.

EN
04/04/2018

Underlying

9MHMedX Health Corp.

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on MedX Health Corp.

 PRESS RELEASE
Free
9MH MedX Health Cor...

MedX to Present at Benzinga Healthcare Conference on September 30th

Mississauga, Ontario--(Newsfile Corp. - September 29, 2021) - (TSXV: MDX) ("MedX" or the "Company"), a global leader in teledermatology, is pleased to announce its participation in the Benzinga Healthcare Small Cap Conference (the "Conference"), taking place virtually on Thursday, September 30th at 4:40 PM ET. MedX President & CEO, Sylvain Desjeans, along with Mike Druhan, President Dermatological Services, will present the Company's vision for scaling access to its unique dermatological image capture technology and fully integrated telemedicine platform, DermSecure®. The screening platform ...

September 29, 2021 1 EN
 PRESS RELEASE
Free
9MH MedX Health Cor...

MedX Health Corp.’s SIAscopy Technology Being Introduced to the Span...

MISSISSAUGA, Ontario--(BUSINESS WIRE)-- MedX Health Corp. (“MedX”) (TSX-V: MDX) announced that it has shipped an initial order in excess of $120,000 of its SIAscopy technology to Spain through its marketing partnership with OncoTech LLC. “Completing this large order early in the second quarter reinforces the growing interest in our technology as a pain-free non-invasive skin assessment tool,” noted Rob von der Porten, MedX's CEO. “OncoTech sees this as a first step in gaining awareness followed by further market penetration i...

May 14, 2018 1 EN
 PRESS RELEASE
Free
9MH MedX Health Cor...

MedX Health Corp. Announces 2017 Year End Results and Granting of Shar...

MISSISSAUGA, Ontario--(BUSINESS WIRE)-- MedX Health Corp. (“MedX” or the “Company”) (TSX-V: MDX) announced its results for the year ended December 31, 2017, which are also available on SEDAR (www.sedar.com). The Company reported revenue of $1,093,239 for the year ended December 31, 2017, an increase of 34% from revenue of $817,055 for the year ended December 31, 2016. Sales from the Company's therapeutic laser line grew by $341,488 during 2017, while revenue from SIAscopy, the Company’s skin assessment technology, was $65,304...

April 30, 2018 1 EN
 PRESS RELEASE
Free
9MH MedX Health Cor...

MedX Health Corp. Adds Experienced Medical Device Professional, Scott ...

MISSISSAUGA, Ontario--(BUSINESS WIRE)-- MedX Health Corp. (“MedX”) (TSX-V: MDX) announced today that Scott Spearn, an experienced medical device executive, joined the MedX team as President. Mr. Spearn has successfully built sales and distribution channels for medical devices across Canada, the United States and Latin America. His focus will be on developing and expanding MedX’s North American and international sales. Mr. Spearn will report to Robert von der Porten, CEO. “With the completion of successful financings and the f...

April 4, 2018 1 EN
 PRESS RELEASE
Free
9MH MedX Health Cor...

MedX Health Corp. Announces Investor Relations Agreement

MISSISSAUGA, Ontario--(BUSINESS WIRE)-- MedX Health Corp. (“MedX” or the “Company”) (TSX-V:MDX). The Company announces that it has received notice from the TSX-V accepting an Investor Relations Agreement entered into with Mi3 Communications Financières Inc. (the “Consultant”) with an effective date of December 1, 2017. Under the terms of the Agreement, the Consultant will carry out activities to develop the Eastern Canada shareholder base of the Company, and the Company will pay to the Consultant a monthly consideration of $5,000, tog...

March 8, 2018 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch